# FDA Inspection 957522 - Sri Krishna Pharmaceuticals Limited - Unit IV - January 22, 2016

Source: https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited-unit-iv/4499ca03-e77c-470c-b545-a912d60fcf44
Source feed: FDA_Inspections

> FDA Inspection 957522 for Sri Krishna Pharmaceuticals Limited - Unit IV on January 22, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 957522
- Company Name: Sri Krishna Pharmaceuticals Limited - Unit IV
- Inspection Date: 2016-01-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269687 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited-unit-iv/09f54070-d5a5-401c-98bd-df48cb83ff0f)
- [FDA Inspection 1269687 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited-unit-iv/4d9f5c64-c47a-4d48-ba6b-6f640da432a8)
- [FDA Inspection 844638 - 2013-07-19](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-limited-unit-iv/a87d4f32-d28d-4736-9da1-6d6086957cba)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited-unit-iv/fd405e8b-b747-4adb-bbb5-da63c0cfa56b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c